N-(1-Acetylpiperidin-4-yl)-4-fluorobenzamide, 97.0%, 100mg

Ethyl 2-chlorothiazole-5-carboxylate, 95.0%, 10g

Methanesulfonic acid ((R)-1-((S)-2-amino-3-methylbutanoyl)pyrrolidin-2-yl)boronic acid (1:1), 95.0%, 10mg

1,4-Dichlorobenzene, 98.0%, 100g

Eosinato azzurro II, per microscopia, 5 g, confezione in vetro

6'-Methyl-3-(4-(methylsulfonyl)phenyl)-2,3'-bipyridine (Etoricoxib Impurity), 97%, 50mg

3-Fluoro-4-iodoquinoline, 97%, 100mg

2,4-Dichloro-6-nitroquinoline, 97%, 250mg

2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-, 95%+, 50g

5-Bromo-2-iodotoluene>98.0%(GC)5g

4-(ethoxycarbonyl)benzoic acid, 95.0%, 500mg

1-CHLORO-2-FLUORO-4-IODO-5-METHOXYBENZENE, 95%, 250mg

3-Fluoro-5-nitro-phenol, 95.0%, 1g